Related Experiment Video
Updated: Feb 4, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Immunology of systemic inflammatory diseases]
1Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland. Martin.Aringer@uniklinikum-dresden.de.
Inflammatory rheumatic diseases stem from immune dysfunction. Key immune cells and cytokines like IL-6, IL-17, and IL-1 are crucial in differentiating autoimmune conditions such as rheumatoid arthritis.
Area of Science:
- Immunology
- Rheumatology
- Systemic Autoimmune Diseases
Background:
- Inflammatory rheumatic diseases are systemic conditions arising from immune system dysregulation.
- Understanding immune system dysfunction is key to managing these diseases.
Purpose of the Study:
- To review the immunological basis of inflammatory rheumatic diseases.
- To highlight the role of immune cells and cytokines in disease pathogenesis.
- To discuss new therapeutic approaches targeting the immune system.
Main Methods:
- Review of pathophysiological processes in the immune system.
- Analysis of laboratory results and autoantibody tests.
- Immunologically focused overview of clinical approaches and novel drugs.
Main Results:
- T and B lymphocytes, along with autoantibodies, confirm the autoimmune nature of rheumatoid arthritis, connective tissue diseases, and vasculitides.
- Cytokine profiles differentiate conditions: IL-6 in RA, IL-17/IL-23 in spondylarthritides, and IL-1 in crystal arthritides.
- Tumor necrosis factor is implicated in numerous inflammatory entities.
Conclusions:
- Rheumatoid arthritis, connective tissue diseases, and vasculitides are autoimmune disorders driven by immune system components.
- Specific cytokines play distinct roles in different inflammatory arthritides, guiding targeted therapies.
- Advances in understanding immune pathways are paving the way for novel treatments.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

